US2008241880A1PendingUtilityA1
Methods and compositions for determination of glycated proteins
Est. expiryJul 17, 2023(expired)· nominal 20-yr term from priority
G01N 33/723C07K 2319/40C07K 2319/50C12N 9/0032C12Q 1/26C12Q 1/37G01N 33/6893G01N 2400/00G01N 2800/042
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates generally to the field of glycated protein detection. In particular, the invention provides chimeric proteins, nucleic acids encoding the chimeric proteins, methods and kits for assaying for a glycated protein in a sample, using inter alia, an amadoriase.
Claims
exact text as granted — not AI-modified1 - 25 . (canceled)
26 : An isolated nucleic acid comprising a nucleotide sequence encoding a chimeric protein comprising, from N-terminus to C-terminus:
a) a first peptidyl fragment comprising the amino acid sequence set forth in SEQ ID NO:1; b) a second peptidyl fragment comprising an amadoriase; and c) a third peptidyl fragment comprising the amino acid sequence set forth in SEQ ID NO:4.
27 . (canceled)
28 : The nucleic acid of claim 26 , which comprises the nucleotide sequence set forth in SEQ ID NO:6
(ATGGGAGGTTCGGGTGACGATGATGACCTGGCTCTCGCCGTCACTAAGT
CATCATCTCTCCTGATCGTTGGTGCCGGGACTTGGGGCACCTCAACGGCT
CTGCACCTCGCGCGCCGCGGATATACCAACGTTACCGTGCTGGACCCCTA
TCCTGTCCCTAGCGCCATCTCCGCCGGAAACGACGTGAACAAAGTCATTA
GCAGTGGCCAATATTCGAATAACAAAGACGAAATCGAAGTGAATGAGATC
TTGGCGGAAGAGGCGTTTAACGGTTGGAAGAACGACCCGCTTTTCAAACC
GTATTATCATGATACGGGCCTGCTGATGTCTGCTTGCTCGCAGGAGGGCC
TGGATCGCCTGGGCGTCCGGGTACGTCCGGGCGAGGATCCTAATCTGGTG
GAACTTACCCGCCCGGAGCAATTTCGTAAACTGGCCCCGGAAGGCGTGTT
GCAAGGTGATTTTCCGGGTTGGAAAGGGTACTTTGCGCGTTCCGGCGCTG
GCTGGGCACATGCAAGGAATGCCTTAGTCGCAGCAGCACGCGAAGCACAG
CGCATGGGTGTAAAATTTGTTACTGGCACCCCGCAGGGTCGTGTAGTCAC
GTTAATCTTTGAAAATAACGATGTAAAAGGTGCCGTTACGGGCGATGGCA
AAATTTGGAGAGCGGAACGTACATTCCTGTGTGCTGGGGCTAGCGCGGGT
CAGTTCCTAGATTTCAAGAATCAACTTCGACCAACCGCTTGGACCCTGGT
ACACATTGCGTTAAAACCGGAAGAACGTGCGTTGTACAAAAATATACCGG
TTATCTTTAACATCGAACGGGGGTTTTTCTTTGAACCCGATGAGGAGCGC
GGTGAGATTAAAATATGCGATGAACACCCGGGCTACACAAATATGGTCCA
GAGTGCAGACGGCACGATGATGAGCATTCCGTTCGAAAAAACCCAGATTC
CAAAAGAAGCCGAAACGCGCGTTCGGGCCCTGCTGAAAGAGACAATGCCC
CAGCTGGCAGACCGTCCATTCAGCTTCGCACGCATTTGCTGGTGTGCCGA
TACCGCGAATCGCGAATTCCTGATACJATCGACATCCGCAGTACCACAGT
CTTGTGTTGGGCTGTGGTGCGAGCGGAAGAGGGTTTAAATATCTGCCTTC
TATTGGGAATCTCATTGTTGACGCGATGGAAGGTAAAGTGCCGCAAAAAA
TTCACGAATTAATCAAGTGGAACCCGGACATTGCGGCGAACCGTAACTGG
CGTGATACTCTGGGGCGTTTTGGCGGTCCAAATCGTGTGATGGATTTTCA
TGATGTGAAGGAATGGACCAATGTTCAGTATCGTGATATTTCCAAGCTGA
AAGGAGAGTTGGAAGGTaaGCCAATCCCTAACCCGTTACTGCGCACAGGC
CATCACCATCATCATCATTAA).
29 : An isolated nucleic acid comprising a nucleotide sequence complementary to the nucleotide sequence of claim 26 .
30 : A recombinant cell containing the nucleic acid of claim 26 .
31 : A method of producing a chimeric protein comprising growing a recombinant cell containing the nucleic acid of claim 26 such that the encoded chimeric protein is expressed by the cell, and recovering the expressed chimeric protein.
32 - 86 . (canceled)
87 : The isolated nucleic acid of the claim 26 , wherein the amadoriase is of Aspergillus sp. origin.
88 : The isolated nucleic acid of the claim 26 , wherein the amadoriase uses FAD as a cofactor.
89 : The isolated nucleic acid of the claim 26 , wherein the amadoriase has a FAD cofactor-binding consensus sequence Gly-X-Gly-X-X-Gly (SEQ ID NO:2), X being any amino acid residue.
90 : The isolated nucleic acid of the claim 26 , wherein the amadoriase is selected from the group consisting of amadoriase Ia, amadoriase Ib, amadoriase Ic and amadoriase II.
91 : The isolated nucleic acid of the claim 26 , wherein the amadoriase comprises the amino acid sequence set forth in SEQ ID NO:3
(AVTKSSSLLIVGAGTWGTSTALHLARRGYTNVTVLDPYPVPSAISAGND
VNKVISSGQYSNNKDEIEVNEILAEEAFNGWKNDPLFKPYYHDTGLLMSA
CSQEGLDRLGVRVRPGEDPNLVELTRPEQFRKLAPEGVLQGDFPGWKGYF
ARSGAGWAHARNALVAAAREAQRMGVKFVTGTPQGRVVTLIFENNDVKGA
VTGDGKIWRAERTFLCAGASAGQFLDFKNQLRPTAWTLVHIALKPEERAL
YKNIPVIFNIERGFFFEPDEERGEIKICDEHPGYTNMVQSADGTMMSIPF
EKTQIPKEAETRVRALLKETMPQLADRPFSFARICWCADTANREFLIDRH
PQYHSLVLGCGASGRGFKYLPSIGNLIVDAMEGKVPQKIHELIKWNPDIA
ANRNWRDTLGRFGGPNRVMDFHDVKEWTNVQYRDISKL).
92 : The isolated nucleic acid of the claim 26 , wherein the chimeric protein further comprises, at its C-terminus, a fourth peptidyl fragment comprising a peptide tag.
93 : The isolated nucleic acid of the claim 92 , wherein the peptide tag is selected from the group consisting of FLAG, HA, HA1, c-Myc, 6-His, AU1, EE, T7, 4A6, {acute over (ε)}, B, gE and Ty1 tag.
94 : The isolated nucleic acid of the claim 26 , wherein the chimeric protein comprises the amino acid sequence set forth in SEQ ID NO:5
(MGGSGDDDDLALAVTKSSSLLIVGAGTWGTSTALHLARRGYTNVTVLDP
YPVPSAISAGNDVNKVISSGQYSNNKDEIEVNEILAEEAFNGWKNDPLFK
PYYHDTGLLMSACSQEGLDRLGVRVRPGEDPNLVELTRPEQFRKLAPEGV
LQGDFPGWKGYFARSGAGWAHARNALVAAAREAQRMGVKFVTGTPQGRVV
TLIFENNDVKGAVTGDGKIWRAERTFLCAGASAGQFLDFKNQLRPTAWTL
VHIALKPEERALYKNIPVIFNIERGFFFEPDEERGEIKICDIEHPGYTNM
VQSADGTMMSIPFEKTQIPKEAETRVRALLKETMPQLADRPFSFARICWC
ADTANREFLIDRHPQYHSLVLGCGASGRGFKYLPSIGNLIVDAMEGKVPQ
KIHELIKWNPDIAANRNWRDTLGRFGGPNRVMDFHDVKEWTNVQYRDISK
LKGELEGLPIPNPLLRTGHHHHHH).
95 : The isolated nucleic acid of the claim 26 , wherein the first and the second peptidyl fragments are linked via a cleavable linkage.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.